MeVis Medical Solutions AG (ETR:M3V)
23.20
-0.20 (-0.85%)
May 29, 2026, 5:35 PM CET
ETR:M3V Revenue
MeVis Medical Solutions AG had revenue of 7.62M EUR in the half year ending September 30, 2025, a decrease of -14.06%. This brings the company's revenue in the last twelve months to 14.95M, down -16.36% year-over-year. In the fiscal year ending September 30, 2025, MeVis Medical Solutions AG had annual revenue of 16.06M, down -5.36%.
Revenue (ttm)
14.95M
Revenue Growth
-16.36%
P/S Ratio
2.73
Revenue / Employee
121.92K
Employees
112
Market Cap
42.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 16.06M | -910.42K | -5.36% |
| Sep 30, 2024 | 16.97M | -370.26K | -2.14% |
| Sep 30, 2023 | 17.34M | -1.42M | -7.57% |
| Sep 30, 2022 | 18.76M | 2.55M | 15.71% |
| Sep 30, 2021 | 16.21M | -916.93K | -5.35% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.24B |
| Siemens Healthineers AG | 23.07B |
| Fresenius SE & Co. KGaA | 22.99B |
| Merck KGaA | 20.96B |
| Maternus-Kliniken Aktiengesellschaft | 118.03M |
| FamiCord AG | 88.17M |
| DocCheck AG | 55.32M |
| aap Implantate AG | 12.80M |
MeVis Medical Solutions AG News
- 10 days ago - MeVis Medical Results & EUR/USD Outlook: 2025/26 Forecast Update - Wallstreet:Online
- 10 days ago - EQS-Adhoc: MeVis Medical Solutions AG: Half-Year Results and Forecast Adjustment for Fiscal Year 2025/2026 - Wallstreet:Online
- 5 months ago - EQS-AFR: MeVis Medical Solutions AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 10 months ago - MeVis Medical Solutions Adjusts 2024/25 Forecast: What to Expect? - Wallstreet:Online
- 10 months ago - EQS-Adhoc: MeVis Medical Solutions AG: Forecast adjustment for the 2024/2025 fiscal year - Wallstreet:Online
- 1 year ago - MeVis Unveils H1 2024/25 Results Amid EUR/USD Trends - Wallstreet:Online
- 1 year ago - EQS-News: MeVis publishes figures for the first half of fiscal year 2024/2025 - Wallstreet:Online
- 1 year ago - EQS-News: MeVis publishes figures for fiscal year 2023/2024 and forecast for 2024/2025 - Wallstreet:Online